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Isoniazid (INH) is a key antitubercular agent, which exhibits poor chemical stability in the solid 
state associated with the hydrazide group.  Cocrystallization with Gentisic Acid having 
antioxidant activity, may produce solid forms with improved pharmaceutical properties. The 
complementary nature of the 
functional groups of isoniazid and 
the chosen coformer resulted in 
success for cocrystal formation. 
Cocrystal (INH-Gentisic acid) 
was characterized by solid-state 
NMR, DSC, PXRD and single 
crystal-XRD. The synthesized 
cocrystals were tested for the 
inhibition of synthetic-free radicals, DPPH. INH-Gentisic acid demonstrated high free radical 
scavenging activity against DPPH (78.36% for 125µg/ml concentration) which were better than 
that of ascorbic acid (37.16%) used as standard. Moreover solubility, stability and flowability 
properties of the synthesized cocrystals are optimized. 
Keywords: Cocrystal, Isoniazid, Gentisic Acid, Physico-chemical properties, Antioxidant 
studies, Flowability studies 
Introduction 
Tuberculosis (TB) is considered as a global emergency by World Health Organization (WHO). 
Fixed-dose combinations (FDCs) based on first line anti-TB drugs are recommended by 
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International Union against Tuberculosis  and Lung Diseases (IUATLD) for the use to avert 
monotherapy as well as drug resistance.[1],[2] Oxidative stress during TB leads to 
hepatotoxicity during the treatment with first-line anti-TB drugs like INH, pyrazinamide and 
Rifampicin (RIF). Oxidation reactions causes the degradation of APIs or tablets in solid form 
effecting the stability and shelf life of pharmaceutical formulations. Antioxidants herbal 
medicines have shown decreased oxidative stress significantly leading to the prediction of 
positive role of antioxidant drugs during anti-TB treatment. [3],[4],[5]  
Isoniazid[6] (INH) is a very efficient remedy against M. tuberculosis recommended by WHO. 
It is first line primary constituent in different FDCs and ‘triple therapy’’ being used to counter 
tuberculosis since 1952. FDCs including RIF and INH have shown apprehension that RIF 
demonstrate alarmingly decreased bioavailability and tablet degradation which can lead to 
therapy failure.[7] RIF and INH yield isonicotinyl hydrazone (HYD) after interacting in solid 
formulation during storage of solid anti-TB FDC formulations under enhanced stability test 
conditions.[8] Moisture absorbance by tablet containing INH and ethambutol was also marked 
under accelerated stability test conditions.[9] These facts leads to subsided efficiency of FDCs 
and needs the attention. 
Pharmaceutical cocrystals renders an opportunity to synthesize a single crystalline form 
consisting of multiple pharmaceutically important compounds.[10] Cocrystals are multi-
component solids held together by non-covalent forces like hydrogen bonding which is well 
studied interaction leading to desired altered[11] physicochemical and stability properties of 
APIs.[12],[13] Screening of cocrystals can be achieved either by solution-based or solid-state 
methods. Solution based procedure involve the slow evaporation of suitable solvent leading to 
crystallization while the other is based on grinding without (neat grinding approach) or with 
the addition of a small amount of solvent (solvent-assisted grinding approach).[14]  
The supramolecular synthon[15] knowledge is important to engineer the synthesis of 
cocrystals. INH is remarkably prone to forming cocrystals with other organic molecules: a 
survey of the Cambridge Structural Database[16] (version 5.41, November 2019) revealed 55 
such structures. INH potential as a supramolecular building block[17] is primarily due to its 
pyridine N atom and the hydrazide group being complementary with carboxylic acid and 
hydroxyl groups, which allows to design particularly stable synthons.[18] Bernstein and co-
workers[19-21] systematically studied cocrystals of INH with carboxylic acids, prospective for 
pharmaceutical applications, and showed the most stable heterosynthon to be an INH-acid pair 
linked by strong C(O)OH···N(pyridine) hydrogen bond (synthon D).  Hydroxyl derivatives of 
benzoic acid, which have antioxidant properties, are thus complementary, and ideal for 
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cocrystallization, with INH.[22] INH cocrystals with Vanillic acid and Caffeic acid, have 
shown increased stability when tested under increased humidity and temperature conditions 
replacing INH in FDCs.[23, 24], Cocrystals of INH with antioxidants may provide relief in 
oxidative stress in patients of Tuberculosis during treatment and increases tabletting shelf 
life[23,25,26] as well. Gentisic (dihydroxybenzoic) acid is an active metabolite of salicylic acid 
degradation and a by-product of tyrosine and benzoate metabolism. It is biologically active and 
show anti-inflammatory, antirheumatic and antioxidant properties. Gentisic acid is readily 
oxidised and is used as an antioxidant excipient in pharmaceutical preparations.[27] It also 
readily forms cocrystals, with 37 structures available in CSD. In the present study a cocrystal 
of INH with Gentisic acid (Scheme 1) was prepared, utilizing both the latter’s supramolecular 
complementarity with INH and its antioxidant activity. 
 
Scheme 1: Synthetic scheme for cocrystallization of INH-Gentisic acid 
Solid-state NMR has recently been applied for the structural insight of cocrystals[28] and can 
be used as complementary technique to X-ray diffraction.[29,30] The field of NMR 
crystallography leverages the synergy between experimental and CASTEP calculated chemical 
shifts. The field of charge–density studies, developed and boosted by advances in hardware, 
provides opportunity to map electron density in a crystal and provide accurate results in the 
calculation of NMR chemical shielding constants for the compounds in the solid state.[31] 
Experimental 
Isoniazid and Gentisic acid were purchased from Sigma-Aldrich and used without further 
purification. 
Synthesis 
INH-Gentisic acid cocrystal was obtained by dissolving 1:1 molar ratio of coformer and INH 
separately in methanol. Both solutions were mixed and heated at 55 oC for 15 minutes with 
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stirring and left at room temperature. Slow evaporation lead to the formation of off white small 
crystals after seven days which were filtered and dried without washing.  
Infrared spectroscopy 
The IR spectra were recorded on Varian 640-IR spectrophotometer. 
Differential Scanning Calorimeter 
Differential Scanning Calorimetry (DSC) experiments were performed by heating from 30 to 
300°C at 10°C per minute in a standard aluminum pan in an inert atmosphere (helium) on 
Perkin Elmer DSC 8500 instrument. DSC experiments were carried out to study the thermal 
behavior of the cocrystals. Melting point can be determined from the melting curve. If the low 
temperature side of melting peak is almost a straight line, the melting point corresponds to the 
onset and if melting curve are concave in shape the melting point are characterized by the peak 
maxima. 
Solid-State NMR Spectroscopy  
Bruker Avance III HD spectrometer was used to obtain the 13C solid state NMR spectra by 
using 13C resonant frequency of 125.7 MHz at 11.7 Tesla magnetic field strength. Nearly 100 
mg of solid sample was packed into a 4 mm rotor made of zirconia equipped with a Kel-F cap. 
The pulse sequence for cross polarization at magic angle spinning (CP-MAS) was used for 
acquisition of spectra. Spinning rate for rotor was set at 10.00 kHz. Magic angle was set by 
calibration using KBr. Spectra were obtained using 180 seconds recycle delay and 320 number 
of scans were taken for cocrystal while the same parameters for INH were 600 seconds and 
120 scans respectively. Data sets were Fourier transformed with line broadening factor at 5 Hz 
and phase corrected to yield frequency-domain spectra. Indirect reference to neat 
tetramethylsilane (TMS) was made for the chemical shifts by setting the high frequency 
adamantane signal at 38.5 ppm. 
1H NMR spectra were also obtained under fast MAS conditions and were acquired using rotors 
of the size of 1.3 at 40.0 kHz MAS frequency and 1H NMR frequency of 500 MHz. The 
chemical shifts were referenced indirectly to neat TMS by setting the adamantane signal at 1.9 
ppm. There was no noticeable difference in 1H resolution consistent with the relatively weak 
dependence of resolution on MAS rate and the likely significant contribution of susceptibility 




Powder X-ray diffraction pattern (2θ range 3-55° at step size 0.02°) was measured at room 
temperature on a Bruker D8 Advance diffractometer equipped with a Lynx-eye Soller PSD 
detector and variable slits, using Cu-Kα1,2 radiation (λ = 1.5418 Å). Polycrystalline samples 
produced by grinding single crystals were sprinkled onto Si slides covered with a thin layer of 
Vaseline.  
Single-crystal diffraction experiment was carried out on a Bruker 3-circle D8 Venture 
diffractometer with a PHOTON 100 CMOS area detector, using Mo-K radiation (λ=0.71073 
Å) from Incoatec IμS micro source with focusing mirrors. The crystal was cooled to 120 K 
using a Cryostream (Oxford Cryosystems) open-flow N2 gas cryostat. The data were processed 
using APEX3 v.2016.1-0 software. Reflection intensities were integrated using SAINT v8.38A 
software (Bruker AXS, 2017) and corrected for absorption by semi-empirical method based on 
Laue equivalents and multiple scans, using SADABS 2016/2 program.[32] The structures were 
solved by dual-space intrinsic phasing method using SHELXT 2018/2 program,[33] and 
refined by full-matrix least squares using SHELXL 2018/3 software[34] on OLEX2 
platform.[35] All non-H atoms were refined in anisotropic approximation, all H atoms were 
revealed from difference Fourier map and refined in isotropic approximation. Crystallographic 
data in CIF format (including structure factors) have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC-1980680. Energies of intermolecular interactions in the 
crystal were calculated in B3LYP/6-31G(d,p) mode, using CrystalExplorer software.[36,37] 
Crystal data: C7H6O4·C6H7N3O (M = 291.26 g/mol), triclinic, space group P1̅ (no. 2), a = 
3.7075(6), b = 10.9505(18), c = 15.966(3) Å, α = 101.366(6), β = 95.706(6), γ = 91.327(6)°, V 
= 631.72(18) Å3, Z = 2, T = 120 K, μ(Mo-Kα) = 0.12 mm-1, Dcalc = 1.531 g/cm
3, 8870 reflections 
with 2 ≤ 50° measured, 2229 unique (Rint = 0.050), 243 refined parameters, R1 = 0.038 on 
1655 reflections with I > 2σ(I), wR2 = 0.093 on all data.  
CASTEP calculations 
GIPAW method implemented in CASTEP version 17.2 was used for first principles.[38] PBE 
functional[39] was used for calculations and on-the-fly-generated ultra-soft pseudopotentials, 
with cut off 600 eV energy. Atomic positions were optimized with the center of mass and unit 
cell parameters fixed as their single crystal XRD-determined values, with integrals taken over 
the Brillouin zone using a Monkhorst–Pack grid with a maximum k-point sample spacing of 
0.1 A–1. Co-ordinate input files were generated from starting CIF files using CIF2cell.[40] 
Crystallographically distinct atoms in the output magres files[41] are labelled using the labels 
in the input CIF files. The NMR parameters were calculated[42,43] using the same k-point 
6 
 
sampling and cut-off energy. The resulting 13C shielding values were transformed into chemical 
shifts by using 164.4 ppm as reference value. 
Solubility, Stability and Dissolution rate studies 
Solubility, Stability and Dissolution rate studies were carried out spectrophotometrically and 
UV-1700, Shimadzu, Japan, equipped with 1.0 cm quartz cuvettes. 200−600 nm range was 
used for this purpose. 
Solubility determination 
Solubility studies of INH-Gentisic acid cocrystal was performed in duplicate according to 
method reported by Higuchi and Connors.[44] In this saturation solubility study, an excess 
quantity of INH and its cocrystal was placed in the vials containing 5 mL of buffer at pH 7.4. 
The vials were agitated on shaker (125 agitations / min) for 24 hrs at room temperature (25 oC). 
The solution was then filtered through syringe filter and the amount of the drug dissolved was 
analysed spectrophotometrically. Concentrations of solutions was determined by UV/vis 
spectrometry and separate linear calibration curve was plotted for cocrystal and INH in the 
range from 339 nm to 266 nm.  
Stability determination 
Stability studies of INH and INH-Gentisic acid cocrystal were performed in duplicate by 
placing known amount of INH and Cocrystals in oven at 80 oC for 24 hrs and then amount of 
the drug and cocrystals was determined spectrophotometrically. 
Dissolution rate determination 
Dissolution rate were determined by dissolving known amount of INH and INH-Gentisic acid 
separately in buffer solution of pH 7.4, Alloquate of 1mL were taken after fixed time intervals 
using syringe filter, equal amount of buffer solution was also added to keep the amount of 
solution constant. Concentration of the solutions were determined spectrophotometrically.  
Flowability properties studies 
Carr’s Index and Hausner Ratio 
Compressibility (Carr’s) index and Hausner ratio calculation is easy, fast, and popular mean to 
predict flow characteristics of pharmaceuticals. It is indirect measurement for size/shape, bulk 
density, surface area, moisture and cohesiveness of the investigated materials.  
The known masses of INH-Gentisic acid was taken in the measuring cylinder, apparent volume 
was noted for the calculation of bulk density. Later the measuring cylinder was tapped for 500 
times and the tapped volume and tapped density was noted. Carr’s index and Hausner ratio 
were determined from the measured values using the equations. 
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Angle of repose 
Resistance to particle movement is calculated by angle of repose and give the qualitative 
picture of the internal cohesive and frictional factors. Triturated sample are made to free fall 
along the walls of a funnel under the action of gravity. The funnel is fixed at a specified height 
and the compounds are made to fall in such a way that they form a heap. The procedure is 
continued until the apex of heap touches the tip of funnel, the radius of the heap is calculated 
and from radius and height, angle of repose is measured by using the following equation. 




Free radical scavenging/antioxidant assay studies 
The DPPH (2,2- diphenyl-1-picrylhydrazyl) free radical scavenging assay was used to find out 
free radical scavenging abilities of the synthesized cocrystal.[45] 0.1mM DPPH control 
solution was prepared in ethanol which was then diluted to adjust its absorbance to 0.70 (at 515 
nm). Sample solutions were prepared by dissolving 1mg/ml from each compounds in ethanol 
followed by double dilution. 2ml of DPPH is added to each compound-containing 1mg/ml 
solutions and incubated in dark for 20min at 37oC. To calculate the percent scavenging of 
DPPH radical by INH-Gentisic acid following equation was used. Absorbance was recorded 
by using VARIAN, CARY 50 Bio. UV-Visible spectrophotometer at 515nm. Antioxidant 
activity was determined with the help of following formula.  
%age Inhibition = B-S/B × 100 
“B” represents the absorbance of the reference/control (DPPH) and “S” represents the sample 
absorbance. 
Results and Discussion 
INH-Gentisic acid cocrystal was synthesized and the solid form was confirmed to be cocrystals 
by characterization using spectroscopic, thermal and X-ray diffraction techniques.  
IR studies 
IR spectrum (Figure 1) of INH showed the stretching of –NH bond in the high wave number 
region of the IR at 3360 cm-1, while the cocrystal showed a sharp band of weak intensity at 
3340 cm-1. Another sharp band was present at 3088cm-1, which was attributed to the C-H 
(aromatic) stretching vibrations while INH showed at 3172 cm-1 for the same bond. C=O 
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stretching vibration was present at 1667 cm-1 for cocrystal while at 1670 cm-1 for INH. C=N 
stretching was observed at 1600 cm-1 for cocrystal and that of INH. Aromatic ring vibrations 
were attributed at 1510 cm-1, 1445 cm-1for cocrystal and at 1500 cm-1,1465 cm-1 for INH. 
Pyridine ring of cocrystal was identified at 1409 cm-1 while the same was identified at 1410 for 
INH. 
 
Figure 1: IR spectra of coformers and Cocrystal 
DSC studies 
DSC results of Cocrystal of isoniazid and Gentisic acid expressed endothermic peak at 178oC. 
Single transition showed the sharp melting point as expressed in Figure 2. 
 
Figure 2: DSC result for INH-Gentisic acid Cocrystal 
PXRD Studies 



















Sharp peaks (Figure 3) depicts the high crystallinity in the structure. Calculated and 
experimental results were in agreement reasonably.  A weak peak at low 2-theta and some 
peaks at high 2-theta do not match the simulated patterns. This showed some impurities from 
coformers in the bulk sample. 
 
Figure 3: Experimental and Simulated PXRD results for INH-Gentisic acid Cocrystal 
Single crystal XRD studies 
INH and Gentisic acid co-crystallize, in equimolar ratio, in a triclinic structure (space group 
P1̅). The asymmetric unit contains one pair of neutral molecules (Figure 4), hydrogen-bonded 
into a D-type synthon.[46] A network of strong hydrogen bonds (Table 1) links these into a 
quilled layer parallel to the (1 1 0) plane (Figure 5). The remarkable feature of the structure, 
setting it apart from all previously reported  INH-acid cocrystals,[19-21] is the chessboard 
arrangement of the component molecules, so that all strong hydrogen bonds (except the 
intramolecular OH···O in the acid) and all synthons are hetero-molecular. The estimated 
energies of intermolecular interactions (Table 1) show that synthon D is indeed the strongest-
bound, as Bernstein el al. have inferred,[19] mainly by electrostatic and polarization terms. The 
next strongest interactions are between coplanar molecules of INH and the acid in the [1 1̅ 0] 
direction, while the interaction at the ‘step’ of the layer are much weaker and in the same 
region, one of the supposedly ‘active’ H atoms at N(3) surprisingly does not participate in any 








4(20) (170, 106 and 96 kJ mol-1, respectively).  
The layers are held together mainly by van der Waals (dispersive) interactions: both the INH 
and the Gentisic acid molecules form segregated π-π stacks with like molecules of adjacent 
layers (related by the translation a). The stacks are slanted, with uniformly separated parallel 
aromatic rings. The interplanar separations are 3.44 Å in INH stacks and 3.32 Å in the acid 
stacks, with the intermolecular energies of -19.8 kJ mol-1 in either case. The INH conformation 
is similar to that in pure solid,[21] apart from stronger twist about the C(10)–C(13) bond, 
34.1(2)° vs 17.8°.  
 
Figure 4: Asymmetric unit in the INH-Gentisic acid cocrystal (= synthon D). Atomic 
displacement ellipsoids are drawn at the 50% probability level. The pyridine and carboxylic 
planes are inclined by 31.6(1)° and the C(12)H···O(2) distance (2.86(2) Å) exceeds the sum 
of van der Waals radii 
Table 1. Hydrogen Bonds D-H···A and total intermolecular energies in INH-Gentisic acid 
Cocrystal 
 
D H A d(D-H)/Å d(H-A)/Å d(D-A)/Å D-H-A/° Etot /kJ mol-1 
O(1) H(1) N(1) 1.07(2) 1.54(2) 2.603(2) 172(2) -50.7 
O(3) H(3) O(2) 0.89(2) 1.76(2) 2.558(2) 148(2) -- 
O(4) H(4) O(5)1 0.88(3) 1.86(3) 2.740(2) 173(2) -39.2 
N(2) H(2) O(3)2 0.90(2) 2.01(2) 2.906(2) 176(2) -34.4 
N(3) H(3B) O(4)3 0.91(2) 2.21(2) 3.114(2) 168(2) -15.8 






Figure 5: Crystal packing in INH-Gentisic acid cocrystal, showing hydrogen bonds (dotted 
lines) and synthon notation: (a) a layer projected onto (1 1 0) plane, (b) side-view of the 
layers. 
Solid state NMR and CASTEP-calculated spectral Studies 
Phase-pure material containing peaks corresponding to the INH-Gentisic acid cocrystal 
structure was detected. No additional peaks corresponding to unreacted coformers were 
identified. Comparison of experimental and CASTEP calculated 13C NMR spectrum (Figure 





Figure 6: 13C solid state NMR spectrum of INH-Gentisic acid cocrystal, comparison of 
experimental and CASTEP calculated 13C NMR spectrum 
 
Figure 7: Comparison of Experimental and CASTEP calculated solid state 1H NMR 
Reference shielding of 164.4 ppm was used which gave better overall agreement in the CSTEP 
calculated and experimental results. Comparison of results is arranged in Table 2. 
Table 2:  Comparison of CASTEP calculated and Experimental chemical shifts 
Label  INH-Gentisic acid Cocrystal 
















Calculated 15N shieldings were also able to identify all N atoms present in the INH-Gentisic 
acid cocrystal shieldings are arranged in Table 3. 
 
Table 3:  CASTEP calculated shielding* for N-NMR 




*These are shieldings rather than referenced shifts. 
Solubility, Stability and Dissolution rate studies 
The INH-Gentisic acid cocrystal showed 7.71 mg/mL solubility in pH 7.4 buffer solution was 
very less as compared to that of Isoniazid with solubility 76.30 mg/mL under the same 
conditions applied. The INH-Gentisic acid cocrystal was fairly stable up to 74.99% at 80 oC 
when placed for 24 hours. INH-Gentisic acid cocrystal exhibited comparable stability to that 
of INH whose stability is 83.86% (Table 4). Most of the component was dissolved in solution 
in about 4 minutes as shown by the data in Table 5 and the graph (Figure 8). 
Table 4: solubility and stability results for INH-Gentisic acid Cocrystal 
C1 175.1 175.8 
C10 140.5 143.9 
C11 120.1 120.8 
C12 147.1 146.5 
C13 164.4 159.0 
C2 111.6 109.8 
C3 153.5 156.2 
C4 117.8 116.3 
C5 124.7 127.0 
C6 150.5 151.5 
C7 112.9 110.5 
C8 143.2 145.3 








Stability at 80oC 
for 24 hrs   
Solubility (in 
buffer pH 7.4) 
ƛmax 
INH White crystal 172oC 83.86% 76.30 mg/mL 263 nm 




 Brown Prism 
178oC 74.99%  7.71 mg/mL 324.6 nm 
 








1 1 0.456 0.807 
2 3 0.521 0.922 
3 5 0.549 0.972 
4 10 0.563 0.996 
5 50 0.605 1.070 
 
 
Figure 8: Dissolution rate of INH-Gentisic acid Cocrystal 
Flowability properties studies 
Cocrystal showed less density when compared to that of INH, however the studied properties 
are in pharmaceutically acceptable ranges and are shown in Table 6. 























Disolution rate for INH-Gentisic acid cocrystal
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Carr’s index Angle of 
repose 
INH 819.67 961.54 1.2 15% 21̊ 
INH-Gentisic acid 
Cocrystal 
129.6 203.7 1.6 36% 40̊ 
 
Free radical scavenging/antioxidant assay studies 
The antioxidant potential of the synthesized bioactive cocrystals were studied using DPPH 
assay. This assay is based on the ability of an antioxidant to scavenge DPPH free radicals. C9 
showed highest scavenging activity with 78.36 % inhibition at 125μg/ml concentration 
compared to reference ascorbic acid with %age inhibition 37.16% at this concentration. The 
results are are summarized in table 7. 
Table 7: Antioxidant Activity results for INH-Gentisic acid Cocrystal 














Isoniazid (INH) forms cocrystal with hydroxyl derivatives of benzoic acids (Gentisic acid) due 
to complementary nature of the functional groups of INH and Gentisic acid. Cocrystal form 
was characterized by solid-state NMR, DSC, PXRD and single crystal-XRD. Cocrystal 
demonstrated free radical scavenging activity against DPPH (78.36% for 125µg/ml 
concentration) which was better than that of ascorbic acid (37.16%). Antioxidant and 
flowability properties suggest that cocrystal may have improved storage stability as hydrazide 
functional group is masked by hydrogen bonding which causes degradation of  Rifampicin and 
antioxidant properties hence cocrystal may replace INH in FDCs used to treat tuberculosis.  
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